The 50-day moving average for CSTL moved above the 200-day moving average on September 15, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 227 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
CSTL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 202 of 227 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.
The 10-day RSI Indicator for CSTL moved out of overbought territory on September 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 28 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CSTL as a result. In 70 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 28 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
CSTL moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.335) is normal, around the industry mean (72.578). P/E Ratio (30.242) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where INSP declined for three days, in 249 of 319 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.
The 10-day RSI Indicator for INSP moved out of overbought territory on September 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 20 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INSP as a result. In 64 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for INSP turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
INSP broke above its upper Bollinger Band on September 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 59 cases where INSP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The 50-day moving average for INSP moved above the 200-day moving average on September 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +7.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where INSP advanced for three days, in 231 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 146 of 199 cases where INSP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. INSP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.451) is normal, around the industry mean (10.930). P/E Ratio (15.453) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.375) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
CSTL | INSP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 43 Fair valued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 50 | |
PRICE GROWTH RATING 1..100 | 38 | 42 | |
P/E GROWTH RATING 1..100 | 99 | 97 | |
SEASONALITY SCORE 1..100 | 85 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CSTL's Valuation (43) in the null industry is in the same range as INSP (57) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to INSP’s over the last 12 months.
CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as INSP (100) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to INSP’s over the last 12 months.
INSP's SMR Rating (50) in the Medical Specialties industry is somewhat better than the same rating for CSTL (92) in the null industry. This means that INSP’s stock grew somewhat faster than CSTL’s over the last 12 months.
CSTL's Price Growth Rating (38) in the null industry is in the same range as INSP (42) in the Medical Specialties industry. This means that CSTL’s stock grew similarly to INSP’s over the last 12 months.
INSP's P/E Growth Rating (97) in the Medical Specialties industry is in the same range as CSTL (99) in the null industry. This means that INSP’s stock grew similarly to CSTL’s over the last 12 months.
| CSTL | INSP | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 78% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 78% | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 85% |
| Advances ODDS (%) | 1 day ago 78% | 3 days ago 82% |
| Declines ODDS (%) | 8 days ago 80% | 1 day ago 78% |
| BollingerBands ODDS (%) | 1 day ago 88% | 6 days ago 71% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 73% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CSTL’s FA Score shows that 0 FA rating(s) are green while INSP’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CSTL’s TA Score shows that 5 TA indicator(s) are bullish while INSP’s TA Score has 4 bullish TA indicator(s).
CSTL (@Medical Specialties) experienced а +0.33% price change this week, while INSP (@Medical/Nursing Services) price change was +0.92% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.43%. For the same industry, the average monthly price growth was -0.17%, and the average quarterly price growth was +34.76%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.79%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -14.87%.
CSTL is expected to report earnings on Nov 09, 2026.
INSP is expected to report earnings on Nov 02, 2026.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-4.79% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.
| Ticker / NAME | Correlation To CSTL | 1D Price Change % | ||
|---|---|---|---|---|
| CSTL | 100% | +0.70% | ||
| TCMD - CSTL | 50% Loosely correlated | +0.45% | ||
| NEO - CSTL | 46% Loosely correlated | +1.32% | ||
| GH - CSTL | 43% Loosely correlated | +0.56% | ||
| ADPT - CSTL | 43% Loosely correlated | +1.34% | ||
| NTRA - CSTL | 39% Loosely correlated | -0.23% | ||
More | ||||
A.I.dvisor indicates that over the last year, INSP has been loosely correlated with VIVO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then VIVO could also see price increases.
| Ticker / NAME | Correlation To INSP | 1D Price Change % | ||
|---|---|---|---|---|
| INSP | 100% | -1.15% | ||
| VIVO - INSP | 41% Loosely correlated | -15.77% | ||
| LIVN - INSP | 38% Loosely correlated | -0.38% | ||
| AZTA - INSP | 37% Loosely correlated | -1.82% | ||
| CSTL - INSP | 35% Loosely correlated | +0.70% | ||
| SIBN - INSP | 34% Loosely correlated | -1.07% | ||
More | ||||